Pinsent Masons expands Life Sciences Group with team hire

18 Feb 2013 | 09:15 am | 1 min. read

International law firm Pinsent Masons has boosted its Life Sciences group with the appointment of a four-strong Partner team.

The team of Paul Ranson, Allistair Booth, Stuart Richards and Charles Waddell - has a market-leading reputation for life sciences IP, regulatory and transactional work. 

They join a formidable Life Sciences team at Pinsent Masons, led by life sciences patent litigator Clare Tunstall, and complete the firm's full-service offering across the sector. 

Paul Ranson is a well-known figure in the Life Sciences world having previously headed the Healthcare group at Simmons & Simmons.

Allistair Booth and Stuart Richards work across corporate, commercial and non-contentious IP matters in the sector. 

Charles Waddell is a well known corporate finance specialist in the sector. His primary focus is advising in the biotechnology and medtech sectors on equity raisings, mergers and acquisitions and other corporate transactions..  The team, which is ranked in the top tier of Life Sciences advisers by leading independent legal directories Chambers and Legal 500, has a strong client base of pharmaceutical, drug delivery, biotech and, medtech companies.

They arrive from the London office of Canadian firm Fasken Martineau and will bring the total number of lateral hires announced by Pinsent Masons in 2013 to seven.

David Ryan, Managing Partner of Pinsent Masons, says:

"We have started the year strongly, with significant hires into those areas where we see the greatest opportunity for growth domestically and internationally, and will continue to make investments in line with our sector-focused strategy.

"These appointments ensure that Pinsent Masons' offering in the Life Sciences sector is unrivalled, providing in depth expertise on business critical issues as well and the ability to deploy 'go to' partner specialists on all business as usual areas.We are therefore delighted that Paul and his colleagues are joining us.”

Latest press releases

Show me all press releases

Pinsent Masons announces FY26 results

Multinational law firm Pinsent Masons has today announced its unaudited financial results for the year ending 30 April 2026. The firm has generated a revenue increase of 3.3% to £703m. Profit per equity partner is £740k. 

Pinsent Masons advises MJM Group on another M&A transaction in the Polish insurance sector

Multinational law firm Pinsent Masons has advised MJM Group, one of the leading brokerage groups in the insurance and reinsurance market, on the acquisition of a 100% stake in Certo Broker and XILIUM. Certo Broker specialises in the distribution of group and health insurance products, while XILIUM provides a digital platform for the administration of group life insurance programmes and health insurance policies.

Pinsent Masons advises Nichols plc on Vit Hit acquisition

Multinational law firm Pinsent Masons has advised British multinational soft drinks company Nichols plc (Nichols) on its acquisition of Vit Hit Limited (VITHIT) for €75 million.

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons announces FY26 results

Multinational law firm Pinsent Masons has today announced its unaudited financial results for the year ending 30 April 2026. The firm has generated a revenue increase of 3.3% to £703m. Profit per equity partner is £740k. 

Pinsent Masons advises Horizon 3 Healthcare on investment in Xeltis

Multinational law firm Pinsent Masons has advised Horizon 3 Healthcare as lead investor in an additional €20.5 million funding round for Xeltis, a clinical-stage medtech company developing transformative implantable medical devices.

Pinsent Masons elects John Maciver as Senior Partner

Multinational law firm Pinsent Masons has elected John Maciver as Senior Partner. 

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts

We are processing your request. \n Thank you for your patience. An error occurred. This could be due to inactivity on the page - please try again.